Department of Medicine, Division of General Internal Medicine, The Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY 11042, USA.
Institute for Health System Science, Center for Health Innovations & Outcomes Research, Feinstein Institutes for Medical Research, Manhasset, NY 11030, USA.
Per Med. 2021 Jul;18(4):347-359. doi: 10.2217/pme-2020-0166. Epub 2021 May 28.
Patients from racial and ethnic minority backgrounds in the USA have historically been under-represented in research trials. Understanding their viewpoints regarding participation in N-of-1 trials is imperative as we design and implement these studies. We conducted six focus groups of racial and ethnic minority patients (n = 25) and providers (n = 9). We used content analysis to identify themes. Our results noted the importance of considering family members in N-of-1 trial recruitment and participation, patients' desire for education as a design feature, for 'lifestyle' changes as a treatment option and for use of nonevidence-based treatments in the design of future N-of-1 trials. Personalized trials have the potential to change the way we deliver primary care and improve disparities for minorities.
美国的少数族裔患者在历史上一直未能充分参与到研究试验中。在我们设计和实施这些研究时,了解他们对参与 N-of-1 试验的观点至关重要。我们对 25 名少数族裔患者和 9 名医疗服务提供者进行了六组焦点小组讨论。我们使用内容分析法来确定主题。我们的研究结果指出,在 N-of-1 试验招募和参与过程中,需要考虑到家庭成员;患者希望将教育作为设计特点;将“生活方式”改变作为治疗选择;以及在未来的 N-of-1 试验设计中使用非循证治疗方法。个性化试验有可能改变我们提供初级保健的方式,并减少少数民族的差异。